Please assess the completion status of the following clinical trial:

Trial Title: CICERO- A Care Home Study of COVID-19

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Persons resident or requiring access to the care home~* Capable of giving written informed consent, or if appropriate, having an acceptable individual capable of giving consent on the participant's behalf.~Exclusion Criteria:~* Persons not providing informed consent or withdrawing consent at any time during the study.~* Persons requiring urgent and immediate access to the care home, for example medical staff attending emergency visits.~* Persons unable to provide nasal or oropharyngeal swabs for medical reasons.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 130 Years
- Healthy Volunteers: t

Study Arms:
- Standard of care (Type: ACTIVE_COMPARATOR): Screening for COVID-19 via nasopharyngeal swab taken at day 0 and 14
- Near Patient Testing (Type: EXPERIMENTAL): Screening for COVID-19 via nasopharyngeal swab taken at day 0 and 14, with the addition of daily nasal swabs tested via rapid test system

Based on this trial design, predict the completion outcome and termination type (if applicable).